RxDoctor Payments Data

Abby Hefner

Nurse Practitioner · la Grange, KYNPI 1043242522

Payments from drug & device makers

$1,766in general payments, 2019–2025

Across 109 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$750
  • Novo Nordisk$259
  • Lilly USA, LLC$134
  • Exact Sciences$119
  • Amgen$84
  • GSK$82
  • plus $337 from 10 others

What the payments were for

  • Food & beverage$1,766100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,766 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$80,622
Medicare patients
213
Services billed
1,150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide103$192,225
TrulicityDulaglutide48$89,452
FarxigaDapagliflozin Propanediol59$71,800
MounjaroTirzepatide51$68,698
EliquisApixaban73$64,879
JardianceEmpagliflozin26$36,198
Xigduo XrDapaglifloz Propaned/Metformin24$26,786
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$25,094
Invokamet XrCanagliflozin/Metformin Hcl15$16,965
Soliqua 100-33Insulin Glargine/Lixisenatide12$15,941
XareltoRivaroxaban13$14,961
Spiriva RespimatTiotropium Bromide21$12,895
Repatha SyringeEvolocumab18$10,685
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$8,825
JanuviaSitagliptin Phosphate12$6,762

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$259$192,225103 claims
Lilly USA, LLCTrulicity, Mounjaro$134$158,14999 claims
AstraZenecaFarxiga$56$71,80059 claims
PfizerEliquis$13$64,87973 claims
GSKTrelegy Ellipta$82$25,09439 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$43$15,94112 claims
MerckJanuvia$23$6,76212 claims
AbbVieSynthroid$750$3,20756 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in la Grange

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →